Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Sales: 2021-2024

Historic Return on Sales for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to -0.10%.

  • Kiniksa Pharmaceuticals International's Return on Sales rose 28.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 28.00%. This contributed to the annual value of -0.10% for FY2024, which is 12.00% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Return on Sales stood at -0.10% for FY2024, which was up 54.33% from -0.22% recorded in FY2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Return on Sales peaked at 26.74% during FY2022, and registered a low of -4.30% during FY2021.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Return on Sales had a median value of -0.10% in 2024 and averaged 8.81%.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Return on Sales skyrocketed by 3,104bps in 2022, and later plummeted by 2,697bps in 2023.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Return on Sales (Yearly) stood at -4.30% in 2021, then spiked by 3,104bps to 26.74% in 2022, then slumped by 2,697bps to -0.22% in 2023, then grew by 12bps to -0.10% in 2024.